RxDoctor Payments Data

Eleuterio Go, MD

Psychiatry · Modesto, CANPI 1447219662

Payments from drug & device makers

$5,136in general payments, 2019–2025

Across 360 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$576
  • Sunovion Pharmaceuticals Inc.$479
  • Otsuka America Pharmaceutical, Inc.$443
  • Lundbeck LLC$394
  • Supernus Pharmaceuticals, Inc.$352
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$5,131100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,136 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$73,974
Medicare patients
38
Services billed
673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate71$112,878
TrintellixVortioxetine Hydrobromide47$26,639
AuvelityDextromethorphan Hbr/Bupropion30$25,783
Lurasidone Hcl111$18,216
RexultiBrexpiprazole11$15,747
Aripiprazole48$7,724
Trazodone Hcl253$2,383
Hydroxyzine Hcl123$1,823
Ziprasidone Hcl18$1,526
Escitalopram Oxalate172$1,507
Quetiapine Fumarate131$1,475
Paliperidone ErPaliperidone22$1,395
Sertraline Hcl182$1,209
Dextroamphetamine Sulfate11$1,187
Fluoxetine Hcl70$1,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$292$112,87871 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$576$26,63947 claims
Axsome Therapeutics, Inc.Auvelity$112$25,78330 claims
Otsuka America Pharmaceutical, Inc.Rexulti$443$15,74711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Modesto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →